{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:26:05Z","timestamp":1792599965920,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Epiphycan (EPYC) has been confirmed to play an oncogenic role in many cancers. However, its role and mechanism in gastric cancer (GC) progression has not been explored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The levels of EPYC and NOP2\/Sun domain 2 (NSUN2) were detected by qRT-PCR and western blot. Cell proliferation, apoptosis, migration and invasion were determined by cell counting kit 8 assay, colony formation assay, flow cytometry, wound healing assay and transwell assay. Fe\n                      <jats:sup>2+<\/jats:sup>\n                      and iron levels were examined to assess cell ferroptosis. Actinomycin D assay was used to detect the effect of NSUN2 knockdown on EPYC mRNA stability, and methylated RNA immunoprecipitation (MeRIP) assay was performed to determine the effect of NSUN2 silencing on 5-methylcytosine (m5C) level of EPYC. Xenograft tumors were constructed to explore the regulation of NSUN2 knockdown on GC tumorigenesis in vivo.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>EPYC was abnormally higher expressed in GC tissues and cells. Knockdown of EPYC restrained GC cell proliferation, migration and invasion, while enhanced apoptosis and ferroptosis. NSUN2 had elevated expression in GC, which could increase the mRNA stability and expression of EPYC through m5C modification. NSUN2 silencing inhibited GC cell proliferation, metastasis, promoted apoptosis and ferroptosis, while these effects were reversed by EPYC overexpression. In vivo experiments revealed that NSUN2 downregulation reduced GC tumorigenesis by decreasing EPYC level in vivo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>NSUN2-mediated m5C modification of EPYC contributed to GC cell growth and metastasis, which provided a novel regulatory axis for understanding the pathogenesis of GC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41065-025-00626-x","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T01:45:35Z","timestamp":1768787135000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["NSUN2 restrains gastric cancer cell apoptosis and ferroptosis by promoting the m5C modification of EPYC"],"prefix":"10.1186","volume":"163","author":[{"given":"Lei","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boxuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"issue":"10251","key":"626_CR1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, et al. Gastric cancer. Lancet. 2020;396(10251):635\u201348.","journal-title":"Lancet"},{"key":"626_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21114012","author":"J Machlowska","year":"2020","unstructured":"Machlowska J, et al. Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21114012.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"626_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-023-01451-3","volume":"16","author":"WL Guan","year":"2023","unstructured":"Guan WL, He Y, Xu RH. Gastric cancer treatment: recent progress and future perspectives. J Hematol Oncol. 2023;16(1):57.","journal-title":"J Hematol Oncol"},{"key":"626_CR4","doi-asserted-by":"crossref","unstructured":"Ajani JA, et al. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022;20(2):167\u2013192.","DOI":"10.6004\/jnccn.2022.0008"},{"issue":"16","key":"626_CR5","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.3748\/wjg.v29.i16.2452","volume":"29","author":"WJ Yang","year":"2023","unstructured":"Yang WJ, et al. Updates on global epidemiology, risk and prognostic factors of gastric cancer. World J Gastroenterol. 2023;29(16):2452\u201368.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"626_CR6","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.trecan.2024.03.008","volume":"10","author":"T Yasuda","year":"2024","unstructured":"Yasuda T, Wang YA. Gastric cancer immunosuppressive microenvironment heterogeneity: implications for therapy development. Trends Cancer. 2024;10(7):627\u201342.","journal-title":"Trends Cancer"},{"issue":"3","key":"626_CR7","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.bbrc.2017.08.092","volume":"492","author":"Y Hanada","year":"2017","unstructured":"Hanada Y, et al. Epiphycan is specifically expressed in cochlear supporting cells and is necessary for normal hearing. Biochem Biophys Res Commun. 2017;492(3):379\u201385.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"626_CR8","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1080\/13816810.2018.1502792","volume":"39","author":"J Lenk","year":"2018","unstructured":"Lenk J, et al. Posterior amorphous corneal dystrophy in a patient with 12q21.33 deletion. Ophthalmic Genet. 2018;39(5):645\u20137.","journal-title":"Ophthalmic Genet"},{"key":"626_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.653782","volume":"11","author":"L Deng","year":"2021","unstructured":"Deng L, et al. Epiphycan predicts poor outcomes and promotes metastasis in ovarian cancer. Front Oncol. 2021;11:653782.","journal-title":"Front Oncol"},{"issue":"1","key":"626_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-51478-w","volume":"14","author":"Z Yang","year":"2024","unstructured":"Yang Z, et al. Epyc functions as a novel prognostic biomarker for pancreatic cancer. Sci Rep. 2024;14(1):719.","journal-title":"Sci Rep"},{"issue":"7","key":"626_CR11","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.cell.2017.05.045","volume":"169","author":"IA Roundtree","year":"2017","unstructured":"Roundtree IA, et al. Dynamic RNA modifications in gene expression regulation. Cell. 2017;169(7):1187\u2013200.","journal-title":"Cell"},{"issue":"756","key":"626_CR12","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adi0178","volume":"16","author":"S Zheng","year":"2024","unstructured":"Zheng S, et al. Extracellular vesicle-packaged PIAT from cancer-associated fibroblasts drives neural remodeling by mediating m5C modification in pancreatic cancer mouse models. Sci Transl Med. 2024;16(756):eadi0178.","journal-title":"Sci Transl Med"},{"issue":"1","key":"626_CR13","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2023.2190618","volume":"55","author":"Y Wang","year":"2023","unstructured":"Wang Y, et al. RNA methylation-related genes of m6A, m5C, and m1A predict prognosis and immunotherapy response in cervical cancer. Ann Med. 2023;55(1):2190618.","journal-title":"Ann Med"},{"issue":"1","key":"626_CR14","first-page":"10","volume":"1","author":"H Zhang","year":"2025","unstructured":"Zhang H, et al. Optimized dynamic network biomarker deciphers a high-resolution heterogeneity within thyroid cancer molecular subtypes. Med Res. 2025;1(1):10\u201331.","journal-title":"Med Res"},{"key":"626_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-012069","author":"P Zhang","year":"2025","unstructured":"Zhang P, et al. Mitochondrial pathway signature (MitoPS) predicts immunotherapy response and reveals NDUFB10 as a key immune regulator in lung adenocarcinoma. J Immunother Cancer. 2025. https:\/\/doi.org\/10.1136\/jitc-2025-012069.","journal-title":"J Immunother Cancer"},{"issue":"8","key":"626_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06049-8","volume":"14","author":"L Fang","year":"2023","unstructured":"Fang L, et al. m5C-methylated lncRNA NR_033928 promotes gastric cancer proliferation by stabilizing GLS mRNA to promote glutamine metabolism reprogramming. Cell Death Dis. 2023;14(8):520.","journal-title":"Cell Death Dis"},{"issue":"1","key":"626_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03427-2","volume":"20","author":"M Li","year":"2022","unstructured":"Li M, et al. 5-methylcytosine RNA methyltransferases and their potential roles in cancer. J Transl Med. 2022;20(1):214.","journal-title":"J Transl Med"},{"issue":"9","key":"626_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04127-3","volume":"12","author":"Y Hu","year":"2021","unstructured":"Hu Y, et al. NSUN2 modified by SUMO-2\/3 promotes gastric cancer progression and regulates mRNA m5C methylation. Cell Death Dis. 2021;12(9):842.","journal-title":"Cell Death Dis"},{"issue":"24","key":"626_CR19","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1038\/s41388-023-02707-5","volume":"42","author":"K Liu","year":"2023","unstructured":"Liu K, et al. Peritoneal high-fat environment promotes peritoneal metastasis of gastric cancer cells through activation of NSUN2-mediated ORAI2 m5C modification. Oncogene. 2023;42(24):1980\u201393.","journal-title":"Oncogene"},{"issue":"7","key":"626_CR20","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1002\/jso.26844","volume":"125","author":"JY Xia","year":"2022","unstructured":"Xia JY, Aadam AA. Advances in screening and detection of gastric cancer. J Surg Oncol. 2022;125(7):1104\u20139.","journal-title":"J Surg Oncol"},{"key":"626_CR21","doi-asserted-by":"crossref","unstructured":"Zeng Y, Jin RU. Molecular pathogenesis, targeted therapies, and future perspectives for gastric cancer. Semin Cancer Biol. 2022;86(Pt 3):566\u2013582.","DOI":"10.1016\/j.semcancer.2021.12.004"},{"issue":"17","key":"626_CR22","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.3748\/wjg.v29.i17.2515","volume":"29","author":"T Matsuoka","year":"2023","unstructured":"Matsuoka T, Yashiro M. Novel biomarkers for early detection of gastric cancer. World J Gastroenterol. 2023;29(17):2515\u201333.","journal-title":"World J Gastroenterol"},{"key":"626_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cells11182828","author":"X Rao","year":"2022","unstructured":"Rao X, et al. Targeting gastric cancer stem cells to enhance treatment response. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11182828.","journal-title":"Cells"},{"issue":"8","key":"626_CR24","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.1167\/iovs.09-4067","volume":"51","author":"AJ Aldave","year":"2010","unstructured":"Aldave AJ, et al. Linkage of posterior amorphous corneal dystrophy to chromosome 12q21.33 and exclusion of coding region mutations in KERA, LUM, DCN, and EPYC. Invest Ophthalmol Vis Sci. 2010;51(8):4006\u201312.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"626_CR25","doi-asserted-by":"crossref","unstructured":"Liang Y, Lin F, Huang Y. Identification of Biomarkers Associated with Diagnosis of Osteoarthritis Patients Based on Bioinformatics and Machine Learning. J Immunol Res. 2022;2022:600190.","DOI":"10.1155\/2022\/5600190"},{"issue":"1","key":"626_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-022-03247-6","volume":"17","author":"J Zhang","year":"2022","unstructured":"Zhang J, et al. KLF9 and EPYC acting as feature genes for osteoarthritis and their association with immune infiltration. J Orthop Surg Res. 2022;17(1):365.","journal-title":"J Orthop Surg Res"},{"key":"626_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073993","author":"H Cherif","year":"2022","unstructured":"Cherif H, et al. Single-cell RNA-Seq analysis of cells from degenerating and non-degenerating intervertebral discs from the same individual reveals new biomarkers for intervertebral disc degeneration. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23073993.","journal-title":"Int J Mol Sci"},{"key":"626_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111375","volume":"123","author":"P Li","year":"2024","unstructured":"Li P, Huang D. NSUN2-mediated RNA methylation: molecular mechanisms and clinical relevance in cancer. Cell Signal. 2024;123:111375.","journal-title":"Cell Signal"},{"key":"626_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cells9081758","author":"A Chellamuthu","year":"2020","unstructured":"Chellamuthu A, Gray SG. The RNA methyltransferase NSUN2 and its potential roles in cancer. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9081758.","journal-title":"Cells"},{"issue":"3","key":"626_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1621","volume":"14","author":"S Zou","year":"2024","unstructured":"Zou S, et al. NSUN2 promotes colorectal cancer progression by enhancing SKIL mRNA stabilization. Clin Transl Med. 2024;14(3):e1621.","journal-title":"Clin Transl Med"},{"issue":"2","key":"626_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05646-x","volume":"14","author":"M Yang","year":"2023","unstructured":"Yang M, et al. NSUN2 promotes osteosarcoma progression by enhancing the stability of FABP5 mRNA via m(5)C methylation. Cell Death Dis. 2023;14(2):125.","journal-title":"Cell Death Dis"},{"key":"626_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102975","volume":"69","author":"SJ Chen","year":"2024","unstructured":"Chen SJ, et al. Epigenetically upregulated NSUN2 confers ferroptosis resistance in endometrial cancer via m(5)C modification of SLC7A11 mRNA. Redox Biol. 2024;69:102975.","journal-title":"Redox Biol"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-025-00626-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00626-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00626-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T19:47:25Z","timestamp":1770839245000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41065-025-00626-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["626"],"URL":"https:\/\/doi.org\/10.1186\/s41065-025-00626-x","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]},"assertion":[{"value":"20 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consents were obtained from all participants and this study was permitted by the Ethics Committee of Xianning Central Hospital, The First Affiliated Hospital of Hubei University of Science and Technology.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consents were obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}